These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27657443)

  • 41. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
    Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A Nanotechnology-Based Platform for Extending the Pharmacokinetic and Binding Properties of Anti-methamphetamine Antibody Fragments.
    Nanaware-Kharade N; Thakkar S; Gonzalez GA; Peterson EC
    Sci Rep; 2015 Jul; 5():12060. PubMed ID: 26159352
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Radioiodinated versus radiometal-labeled anti-carcinoembryonic antigen single-chain Fv-Fc antibody fragments: optimal pharmacokinetics for therapy.
    Kenanova V; Olafsen T; Williams LE; Ruel NH; Longmate J; Yazaki PJ; Shively JE; Colcher D; Raubitschek AA; Wu AM
    Cancer Res; 2007 Jan; 67(2):718-26. PubMed ID: 17234783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of piritramide in newborns, infants and young children in intensive care units.
    Müller C; Kremer W; Harlfinger S; Doroshyenko O; Jetter A; Hering F; Hünseler C; Roth B; Theisohn M
    Eur J Pediatr; 2006 Apr; 165(4):229-39. PubMed ID: 16496200
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation.
    Brinkmann U; Di Carlo A; Vasmatzis G; Kurochkina N; Beers R; Lee B; Pastan I
    J Mol Biol; 1997 Apr; 268(1):107-17. PubMed ID: 9149145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Production of a single chain anti-CEA antibody from the hybridoma cell line T84.66 using a modified colony-lift selection procedure to detect antigen-positive ScFv bacterial clones.
    Rodenburg CM; Mernaugh R; Bilbao G; Khazaeli MB
    Hybridoma; 1998 Feb; 17(1):1-8. PubMed ID: 9523232
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limited diversity of human scFv fragments isolated by panning a synthetic phage-display scFv library with cultured human melanoma cells.
    Noronha EJ; Wang X; Desai SA; Kageshita T; Ferrone S
    J Immunol; 1998 Sep; 161(6):2968-76. PubMed ID: 9743360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multimerization of anti-(epidermal growth factor receptor) IgG fragments induces an antitumor effect: the case for humanized 528 scFv multimers.
    Asano R; Hagiwara Y; Koyama N; Masakari Y; Orimo R; Arai K; Ogata H; Furumoto S; Umetsu M; Kumagai I
    FEBS J; 2013 Oct; 280(19):4816-26. PubMed ID: 23890417
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody Drug Conjugates Differentiate Uptake and DNA Alkylation of Pyrrolobenzodiazepines in Tumors from Organs of Xenograft Mice.
    Ma Y; Khojasteh SC; Hop CE; Erickson HK; Polson A; Pillow TH; Yu SF; Wang H; Dragovich PS; Zhang D
    Drug Metab Dispos; 2016 Dec; 44(12):1958-1962. PubMed ID: 27683653
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design, synthesis and evaluation of anti-CD123 antibody drug conjugates.
    Li B; Zhao W; Zhang X; Wang J; Luo X; Baker SD; Jordan CT; Dong Y
    Bioorg Med Chem; 2016 Nov; 24(22):5855-5860. PubMed ID: 27687970
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a Novel Antibody-Drug Conjugate for the Potential Treatment of Ovarian, Lung, and Renal Cell Carcinoma Expressing TIM-1.
    Thomas LJ; Vitale L; O'Neill T; Dolnick RY; Wallace PK; Minderman H; Gergel LE; Forsberg EM; Boyer JM; Storey JR; Pilsmaker CD; Hammond RA; Widger J; Sundarapandiyan K; Crocker A; Marsh HC; Keler T
    Mol Cancer Ther; 2016 Dec; 15(12):2946-2954. PubMed ID: 27671527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liver Microvascular Injury and Thrombocytopenia of Antibody-Calicheamicin Conjugates in Cynomolgus Monkeys-Mechanism and Monitoring.
    Guffroy M; Falahatpisheh H; Biddle K; Kreeger J; Obert L; Walters K; Goldstein R; Boucher G; Coskran T; Reagan W; Sullivan D; Huang C; Sokolowski S; Giovanelli R; Gerber HP; Finkelstein M; Khan N
    Clin Cancer Res; 2017 Apr; 23(7):1760-1770. PubMed ID: 27683177
    [No Abstract]   [Full Text] [Related]  

  • 53. Enhanced therapeutic potential of antibody fragment via IEDDA-mediated site-specific albumin conjugation.
    Go EB; Lee JH; Cho JH; Kwon NH; Choi JI; Kwon I
    J Biol Eng; 2024 Apr; 18(1):23. PubMed ID: 38576037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The present and future of immunocytokines for cancer treatment.
    Gout DY; Groen LS; van Egmond M
    Cell Mol Life Sci; 2022 Sep; 79(10):509. PubMed ID: 36066630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A very long-acting IL-15: implications for the immunotherapy of cancer.
    Hangasky JA; Chen W; Dubois SP; Daenthanasanmak A; Müller JR; Reid R; Waldmann TA; Santi DV
    J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic Analysis of a Novel Human EGFRvIII:CD3 Bispecific Antibody in Plasma and Whole Blood Using a High-Resolution Targeted Mass Spectrometry Approach.
    Schaller TH; Foster MW; Thompson JW; Spasojevic I; Normantaite D; Moseley MA; Sanchez-Perez L; Sampson JH
    J Proteome Res; 2019 Aug; 18(8):3032-3041. PubMed ID: 31267741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Review of Current Cell-Penetrating Antibody Developments for HIV-1 Therapy.
    Che Nordin MA; Teow SY
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29415435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Approach for Half-Life Extension of Small Antibody Fragments That Does Not Affect Tissue Uptake.
    Schneider EL; Hearn BR; Pfaff SJ; Fontaine SD; Reid R; Ashley GW; Grabulovski S; Strassberger V; Vogt L; Jung T; Santi DV
    Bioconjug Chem; 2016 Oct; 27(10):2534-2539. PubMed ID: 27657443
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary deuterium kinetic isotope effects prolong drug release and polymer biodegradation in a drug delivery system.
    Hearn BR; Fontaine SD; Pfaff SJ; Schneider EL; Henise J; Ashley GW; Santi DV
    J Control Release; 2018 May; 278():74-79. PubMed ID: 29577950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hydrogel Drug Delivery System Using Self-Cleaving Covalent Linkers for Once-a-Week Administration of Exenatide.
    Schneider EL; Henise J; Reid R; Ashley GW; Santi DV
    Bioconjug Chem; 2016 May; 27(5):1210-5. PubMed ID: 26930186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.